STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension
ContributorsBarst, Robyn J; Beghetti, Maurice; Pulido, Tomas; Layton, Gary; Konourina, Irina; Zhang, Min; Ivy, D Dunbar
Published inCirculation, vol. 129, no. 19, p. 1914-1923
Publication date2014
Abstract
Keywords
- Administration, Oral
- Adolescent
- Child
- Child, Preschool
- Dose-Response Relationship, Drug
- Double-Blind Method
- Exercise Tolerance/drug effects/physiology
- Familial Primary Pulmonary Hypertension
- Female
- Hemodynamics/drug effects/physiology
- Humans
- Hypertension, Pulmonary/drug therapy/mortality/physiopathology
- Infant
- Kaplan-Meier Estimate
- Male
- Piperazines/administration & dosage
- Purines/administration & dosage
- Regression Analysis
- Sulfones/administration & dosage
- Survival Rate
- Time Factors
- Treatment Outcome
- Vasodilator Agents/administration & dosage
Research group
Citation (ISO format)
BARST, Robyn J et al. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension. In: Circulation, 2014, vol. 129, n° 19, p. 1914–1923. doi: 10.1161/CIRCULATIONAHA.113.005698
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55241
- DOI : 10.1161/CIRCULATIONAHA.113.005698
- PMID : 24637559
ISSN of the journal0009-7322